3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Respiratory Distress Syndrome
1
Prostatic Neoplasms
1
Pneumonia, Viral
1
Oligodendroglioma
1
Melanoma
1
Hodgkin Disease
1
High-Grade Anal Intraepithelial Neoplasia
1
Hematologic Neoplasms
1
HIV Infections
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Ependymoma
1
Cytokine Release Syndrome
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Astrocytoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
Doxorubicin
10
Zidovudine
9
Vincristine
7
Bleomycin
7
Nivolumab
6
Liposomes
5
Interferon alpha-2
5
Etoposide
5
tecogalan
4
pembrolizumab
4
liposomal doxorubicin
4
Valganciclovir
4
Specimen Handling
4
Semaxinib
4
Paclitaxel
4
Nelfinavir
4
Magnetic Resonance Spectroscopy
4
pomalidomide
3
Ritonavir
3
Filgrastim
3
Biopsy
3
Bevacizumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
2
sargramostim
2
interferon alfa-n1
2
Propranolol
2
Indinavir
2
Docetaxel
2
Didanosine
2
Daunorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sarcoma, Kaposi
×
Lopinavir
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled